Investing Profile

Martin Alexander Gershon(23)

CEOInvestorFounderVC
Endeavor Life Science Venture Funds is a Series B evergreen fund and Seed and Series A Venture Studio.
gershoncapital.comNew York, New York
Photo of Martin Alexander Gershon, Managing Partner at Endeavor Venture Funds

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Endeavor Venture Funds Managing Partner
$500K - $25.0M
$10.0M
95
CompanyStageDateRound SizeTotal Raised
QuantHealth
Series AAug 2023$2.5M
$18M
Co-investors: Cris De Luca (Sanofi Ventures), Ittai Harel (Pitango Venture Capital)
Viome Life Sciences
Series CAug 2023$10M
$10M
Fertifa
Seed Jun 2023$650K
$7.7M
Co-investors: Deepali Nangia (Speedinvest), Malin Posern (Passion Capital), Itxaso del Palacio (Notion Capital), Eileen Burbidge (Passion Capital), Manuel Antunes (MSM), Jonathan Lenson, Tom Blomfield, Jeremy Yap, Mike Hudack, Adam Knight
Alto Neuroscience
Series BJan 2023$7M
$130M
Co-investors: Michael Liang (Baird Capital), Stephen Hays (What If Ventures), Tim Kendall
PVmed
Series BDec 2022$70K
$70K
BehaVR
Series BDec 2022$1M
$2M
Co-investors: Enke Bashllari (Arkitekt Ventures), Kelby Price (Keyhorse Capital)
SaVia Health
SeedDec 2022$1M
$10M
Co-investors: Eric King (Intel Capital), Jen Ard (Intel Capital)
Cardiosense
Series ADec 2022$3M
$18M
Co-investors: Jeff Terrell (Hatteras Venture Partners), Daniel Gottlieb (Broadview Ventures)